Literature DB >> 2150739

Osmolality and pH of anti-asthmatic drug solutions.

K N Desager1, H P Van Bever, W J Stevens.   

Abstract

Mixtures of different drugs are frequently used in aerosol solution for treatment of asthma. These drugs have different pH and osmolality values as stock solutions. It has been suggested that acidity and osmolality interact in provoking bronchoconstriction and cough. Therefore, pH and osmolality of anti-asthmatic drug solutions and mixtures were measured in the nebulizer at 0, 1, 2, 5, 10 and 15 minutes of nebulisation, pH of fenoterol, ipratropium bromide, salbutamol and disodium cromoglycate ranged between 2.0 and 5.7 and did not change during nebulisation. Nearly all drug solutions were hypoosmolar and the osmolality increased during nebulisation with 11 to 62%. Therefore, it is suggested to dilute these drugs with saline 0.9% and to restrict nebulisation time to 10 minutes, since the most striking increase of osmolality was noted after 10 minutes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2150739     DOI: 10.1007/bf01997612

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  13 in total

1.  Properties of aerosols produced with three nebulizers.

Authors:  G A Ferron; K F Kerrebijn; J Weber
Journal:  Am Rev Respir Dis       Date:  1976-11

2.  Acidity potentiates bronchoconstriction induced by hypoosmolar aerosols.

Authors:  J R Balmes; J M Fine; D Christian; T Gordon; D Sheppard
Journal:  Am Rev Respir Dis       Date:  1988-07

3.  Effects of pH and osmolarity on aerosol-induced cough in normal volunteers.

Authors:  R H Lowry; A M Wood; T W Higenbottam
Journal:  Clin Sci (Lond)       Date:  1988-04       Impact factor: 6.124

4.  Osmolality changes in nebulizer solutions.

Authors:  M H Schöni; R Kraemer
Journal:  Eur Respir J       Date:  1989-10       Impact factor: 16.671

5.  The nebuliser epidemic.

Authors: 
Journal:  Lancet       Date:  1984-10-06       Impact factor: 79.321

6.  Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants.

Authors:  C O'Callaghan; A D Milner; A Swarbrick
Journal:  Lancet       Date:  1986 Dec 20-27       Impact factor: 79.321

7.  Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81.

Authors:  G Keating; E A Mitchell; R Jackson; R Beaglehole; H Rea
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-11

8.  The role of titratable acidity in acid aerosol-induced bronchoconstriction.

Authors:  J M Fine; T Gordon; J E Thompson; D Sheppard
Journal:  Am Rev Respir Dis       Date:  1987-04

9.  Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline.

Authors:  R E Schoeffel; S D Anderson; R E Altounyan
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-14

10.  Domiciliary nebulisers in asthma: a district survey.

Authors:  C M Laroche; A V Harries; R C Newton; M G Britton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-01
View more
  2 in total

Review 1.  Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.

Authors:  G Christopher Wood; Joseph M Swanson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Metered dose inhaler and nebuliser in acute asthma.

Authors:  Y Z Lin; K H Hsieh
Journal:  Arch Dis Child       Date:  1995-03       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.